| 慈濟大學 |
2007 |
Villous Adenoma of the Ureter with Manifestation of Mucus Hydroureteronephrosis
|
Shih, Chi-Min;Wu, Sheng-Chuan;Lee, Chueng-Chen;Pan, Chin-Chen |
| 國立成功大學 |
2019 |
Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration
|
Wang, R.-C.;Medeiros, L.J.;Chang, K.-C. |
| 國立臺灣大學 |
2016 |
Vilse在細胞存活與神經發育中功能之研究
|
李晉毓; Lee, Jin-Yu |
| 亞洲大學 |
2015-07 |
Vilsmeier reagent initialed sequential one-pot multicomponent synthesis of N,O-disubstituted glycolamides as dipeptidyl peptidase 4 inhibitors
|
Tsai, 蔡建鈞；Henry J |
| 亞洲大學 |
2015-07 |
Vilsmeier reagent initialed sequential one-pot multicomponent synthesis of N,O-disubstituted glycolamides as dipeptidyl peptidase 4 inhibitors
|
Tsai), 蔡建鈞(Henry J |
| 中國醫藥大學 |
2015-08 |
Vilsmeier reagent initialed sequential one-pot multicomponent synthesis of N,O-disubstituted glycolamides as dipeptidyl peptidase 4 inhibitors
|
呂詩涵(Shi-Han Lu);嚴婉萍(Yen, Wan-Ping);(Henry J. Tsai);(Chien-Shu Chen);翁豐富(Fung-Fuh Wong)* |
| 中國醫藥大學 |
2015-05 |
Vilsmeier reagent mediated synthesis of 6-[(formyloxy)methyl]-pyrazolopyrimidines via one-pot multiple tandem reaction
|
呂詩涵(Shi-Han Lu);劉柏麟(Po-Lin Liu);翁豐富(Fung-Fuh Wong)* |
| 中國醫藥大學 |
2015-04 |
Vilsmeier–Haack reagent-promoted formyloxylation of a-chloro-N-arylacetamides by formamide
|
(Jiann-Jyh Huang);呂詩涵(Shi-Han Lu,);(Yu Hsuan Chung);翁豐富(Fung-Fuh Wong)* |
| 中國醫藥大學 |
2015-06-08 |
Vilsmeier試劑誘發一鍋多步化合成一系列N,O-Disubstituted Glycolamide Esters衍生物作為DPP-4抑制劑
|
呂詩涵;Shih-Han Lu |
| 臺北醫學大學 |
2011 |
Vimax foaming solution 25mlbot 可易適 泡沫液
|
藥劑部藥師 |
| 國立成功大學 |
2015-06-30 |
Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
|
Liu, Ching-Yi; Lin, Hsi-Hui; Tang, Ming-Jer; Wang, Yang-Kao |
| 國立臺灣大學 |
2010 |
Vimentin interacts with heterogeneous nuclear ribonucleoproteins and dengue nonstructural protein 1 and is important for viral replication and release
|
Kanlaya, Rattiyaporn; Pattanakitsakul, Sa-nga; Sinchaikul, Supachok; Chen, Shui-Tein; Thongboonkerd, Visith |
| 中國醫藥大學 |
2010 |
Vimentin is a novel AKT1 target mediating motility and invasion
|
(Zhu QS); (Rosenblatt K); (Huang KL); (Lahat G); (Brobey R); (Bolshakov S,); (Nguyen T); (Ding Z); (Belousov R); (Bill K); (Lazar A); (Dicker A); (Mills GB); 洪明奇(Mien-Chie Hung); (Lev D)* |
| 國立成功大學 |
2017 |
Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins
|
Liu, P.-F.;Kang, B.-H.;Wu, Y.-M.;Sun, J.-H.;Yen, L.-M.;Fu, T.-Y.;Lin, Y.-C.;Liou, H.-H.;Lin, Y.-S.;Sie, H.-C.;Hsieh, I.-C.;Tseng, Y.-K.;Shu, C.-W.;Hsieh, Y.-D.;Ger, L.-P. |
| 朝陽科技大學 |
2014 |
Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated jurkat cells.
|
廖雅芳 |
| 中山醫學大學 |
2014 |
Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.
|
Hsu, PC; YF, Liao; CL, Lin; Lin, WH; GY, Liu; Hung, HC |
| 中山醫學大學 |
2011 |
Vimentin Participates in Peptidylarginine Deiminase 2 Induced Apoptosis in Activated Jurkat Cells
|
Liu, Guang-Yaw |
| 淡江大學 |
2006-02 |
Vinculacion historico-cultural de la sociedad taiwanesa
|
林惠瑛 |
| 國家衛生研究院 |
2023-01 |
Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis
|
Shih, YT;Wei, SY;Chen, JH;Wang, WL;Wu, HY;Wang, MC;Lin, CY;Lee, PL;Lin, CY;Chiang, HC;Chen, YJ;Chien, S;Chiu, JJ |
| 國立臺北護理健康大學 |
2012 |
Vinegar for decreasing catheter-associated bacteriuria in long-term catheterized patients: A randomized controlled trial
|
葉美玲; Chung, Yu-Chu;Chen, Hsing-Hsia;Yeh, Mei-Ling |
| 元培科技大學 |
2012-07 |
Vinegar for decreasing catheter-associated bacteriuria in long-term catheterized patients: a randomized controlled trial.
|
Chung, YC;Chen, HH;Yeh, ML |
| 元培科技大學 |
102 |
Vinegar for decreasing catheter-associated bacteriuria in long-term catheterized patients: a randomized controlled trial.
|
Chung, YC;Chen, HH;Yeh, ML. |
| 元培科技大學 |
2012-07 |
Vinegar for Decreasing Catheter-Associated Bacteriuria in Long-Term Catheterized Patients: A randomized controlled trial.
|
鍾玉珠（Chung, Yu-Chu） |
| 國立成功大學 |
2016-03 |
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
|
De Santis, M.;Wiechno, P. J.;Bellmunt, J.;Lucas, C.;Su, W. -C.;Albiges, L.;Lin, C. -C.;Senkus-Konefka, E.;Flechon, A.;Mourey, L.;Necchi, A.;Loidl, W. C.;Retz, M. M.;Vaissiere, N.;Culine, S. |
| 臺大學術典藏 |
2020-05-25T07:35:19Z |
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)
|
De Santis M; Wiechno P.J; Bellmunt J; Lucas C; Su W.-C; Albiges L; Chia-Chi Lin; Senkus-Konefka E; Flechon A; Mourey L; Necchi A; Loidl W.C; Retz M.M; Vaissi?re N; Culine S. |
